SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Diversa Corporation (DVSA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (20)10/17/2000 8:18:55 AM
From: Capt   of 144
 
Diversa Corporation (Nasdaq: DVSA - news) today reported revenues of $5.6 million for the quarter ended September 30, 2000, a 40% increase over third quarter 1999 revenues, and $15.4 million for the nine months ended September 30, 2000, a 138% increase over revenues for the same period in 1999. The net loss was $1.4 million, or $0.04 per share, in the third quarter of 2000, compared to a net loss of $84 thousand in the third quarter of 1999. Net loss for the nine months ended September 30, 2000 was $8.0 million, or $0.24 per share on a pro forma basis, compared to a net loss of $7.0 million, or $0.28 per share on a pro forma basis, for the same period in 1999. The reported losses for 2000 include non-cash, stock-based compensation charges of $1.6 million and $9.0 million for the quarter and year to date, respectively.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext